Home / Inspections / 1276299

FDA Inspection 1276299 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1076406

The FDA completed an inspection of Octapharma Plasma, Inc. on July 9, 2025 in North Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 9, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Charleston, SC (United States)

Facility

Other inspections at this facility

  • 1053668 (NAI Thu May 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 930212 (VAI Fri May 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 760964 (VAI Fri Dec 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 615510 (NAI Fri Sep 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources